Leerink Swann LLC and Oppenheimer & Co. Inc.
"Leerink Swann LLC and Oppenheimer & Co. Inc. will act as joint book-running managers for the offering." So they obviously intend on roping together various underwriters...
If the underwriting was secured then why make this statement- "The Audeo Fundraising and IPO will only Complete if Audeo Oncology signs an underwriting agreement for an amount, not exceeding US$60 million"
Add to My Watchlist
What is My Watchlist?